Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment()

Detalles Bibliográficos
Autores principales: Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. The Japanese Respiratory Society. Published by Elsevier B.V. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974361/
https://www.ncbi.nlm.nih.gov/pubmed/36907110
http://dx.doi.org/10.1016/j.resinv.2023.02.001
_version_ 1784898710778413056
author Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_facet Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
author_sort Mungmunpuntipantip, Rujittika
collection PubMed
description
format Online
Article
Text
id pubmed-9974361
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Japanese Respiratory Society. The Japanese Respiratory Society. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-99743612023-03-01 Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment() Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Respir Investig Letter to the Editor The Japanese Respiratory Society. The Japanese Respiratory Society. Published by Elsevier B.V. 2023-05 2023-03-01 /pmc/articles/PMC9974361/ /pubmed/36907110 http://dx.doi.org/10.1016/j.resinv.2023.02.001 Text en © 2023 The Japanese Respiratory Society. The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment()
title Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment()
title_full Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment()
title_fullStr Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment()
title_full_unstemmed Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment()
title_short Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment()
title_sort antibody responses to second doses of covid-19 vaccination in lung cancer patients: comment()
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974361/
https://www.ncbi.nlm.nih.gov/pubmed/36907110
http://dx.doi.org/10.1016/j.resinv.2023.02.001
work_keys_str_mv AT mungmunpuntipantiprujittika antibodyresponsestoseconddosesofcovid19vaccinationinlungcancerpatientscomment
AT wiwanitkitviroj antibodyresponsestoseconddosesofcovid19vaccinationinlungcancerpatientscomment

Ejemplares similares